30,140 research outputs found
Identification of causal genes for complex traits.
MotivationAlthough genome-wide association studies (GWAS) have identified thousands of variants associated with common diseases and complex traits, only a handful of these variants are validated to be causal. We consider 'causal variants' as variants which are responsible for the association signal at a locus. As opposed to association studies that benefit from linkage disequilibrium (LD), the main challenge in identifying causal variants at associated loci lies in distinguishing among the many closely correlated variants due to LD. This is particularly important for model organisms such as inbred mice, where LD extends much further than in human populations, resulting in large stretches of the genome with significantly associated variants. Furthermore, these model organisms are highly structured and require correction for population structure to remove potential spurious associations.ResultsIn this work, we propose CAVIAR-Gene (CAusal Variants Identification in Associated Regions), a novel method that is able to operate across large LD regions of the genome while also correcting for population structure. A key feature of our approach is that it provides as output a minimally sized set of genes that captures the genes which harbor causal variants with probability ρ. Through extensive simulations, we demonstrate that our method not only speeds up computation, but also have an average of 10% higher recall rate compared with the existing approaches. We validate our method using a real mouse high-density lipoprotein data (HDL) and show that CAVIAR-Gene is able to identify Apoa2 (a gene known to harbor causal variants for HDL), while reducing the number of genes that need to be tested for functionality by a factor of 2.Availability and implementationSoftware is freely available for download at genetics.cs.ucla.edu/caviar
The Decay of Disease Association with Declining Linkage Disequilibrium: A Fine Mapping Theorem
Several important and fundamental aspects of disease genetics models have yet to be described. One such property is the relationship of disease association statistics at a marker site closely linked to a disease causing site. A complete description of this two-locus system is of particular importance to experimental efforts to fine map association signals for complex diseases. Here, we present a simple relationship between disease association statistics and the decline of linkage disequilibrium from a causal site. Specifically, the ratio of Chi-square disease association statistics at a marker site and causal site is equivalent to the standard measure of pairwise linkage disequilibrium, r2. A complete derivation of this relationship from a general disease model is shown. Quite interestingly, this relationship holds across all modes of inheritance. Extensive Monte Carlo simulations using a disease genetics model applied to chromosomes subjected to a standard model of recombination are employed to better understand the variation around this fine mapping theorem due to sampling effects. We also use this relationship to provide a framework for estimating properties of a non-interrogated causal site using data at closely linked markers. Lastly, we apply this way of examining association data from high-density genotyping in a large, publicly-available data set investigating extreme BMI. We anticipate that understanding the patterns of disease association decay with declining linkage disequilibrium from a causal site will enable more powerful fine mapping methods and provide new avenues for identifying causal sites/genes from fine-mapping studies
Methodological Issues in Multistage Genome-Wide Association Studies
Because of the high cost of commercial genotyping chip technologies, many
investigations have used a two-stage design for genome-wide association
studies, using part of the sample for an initial discovery of ``promising''
SNPs at a less stringent significance level and the remainder in a joint
analysis of just these SNPs using custom genotyping. Typical cost savings of
about 50% are possible with this design to obtain comparable levels of overall
type I error and power by using about half the sample for stage I and carrying
about 0.1% of SNPs forward to the second stage, the optimal design depending
primarily upon the ratio of costs per genotype for stages I and II. However,
with the rapidly declining costs of the commercial panels, the generally low
observed ORs of current studies, and many studies aiming to test multiple
hypotheses and multiple endpoints, many investigators are abandoning the
two-stage design in favor of simply genotyping all available subjects using a
standard high-density panel. Concern is sometimes raised about the absence of a
``replication'' panel in this approach, as required by some high-profile
journals, but it must be appreciated that the two-stage design is not a
discovery/replication design but simply a more efficient design for discovery
using a joint analysis of the data from both stages. Once a subset of
highly-significant associations has been discovered, a truly independent
``exact replication'' study is needed in a similar population of the same
promising SNPs using similar methods.Comment: Published in at http://dx.doi.org/10.1214/09-STS288 the Statistical
Science (http://www.imstat.org/sts/) by the Institute of Mathematical
Statistics (http://www.imstat.org
Recommended from our members
Allele-specific NKX2-5 binding underlies multiple genetic associations with human electrocardiographic traits.
The cardiac transcription factor (TF) gene NKX2-5 has been associated with electrocardiographic (EKG) traits through genome-wide association studies (GWASs), but the extent to which differential binding of NKX2-5 at common regulatory variants contributes to these traits has not yet been studied. We analyzed transcriptomic and epigenomic data from induced pluripotent stem cell-derived cardiomyocytes from seven related individuals, and identified ~2,000 single-nucleotide variants associated with allele-specific effects (ASE-SNVs) on NKX2-5 binding. NKX2-5 ASE-SNVs were enriched for altered TF motifs, for heart-specific expression quantitative trait loci and for EKG GWAS signals. Using fine-mapping combined with epigenomic data from induced pluripotent stem cell-derived cardiomyocytes, we prioritized candidate causal variants for EKG traits, many of which were NKX2-5 ASE-SNVs. Experimentally characterizing two NKX2-5 ASE-SNVs (rs3807989 and rs590041) showed that they modulate the expression of target genes via differential protein binding in cardiac cells, indicating that they are functional variants underlying EKG GWAS signals. Our results show that differential NKX2-5 binding at numerous regulatory variants across the genome contributes to EKG phenotypes
Recommended from our members
Rare variants contribute disproportionately to quantitative trait variation in yeast.
How variants with different frequencies contribute to trait variation is a central question in genetics. We use a unique model system to disentangle the contributions of common and rare variants to quantitative traits. We generated ~14,000 progeny from crosses among 16 diverse yeast strains and identified thousands of quantitative trait loci (QTLs) for 38 traits. We combined our results with sequencing data for 1011 yeast isolates to show that rare variants make a disproportionate contribution to trait variation. Evolutionary analyses revealed that this contribution is driven by rare variants that arose recently, and that negative selection has shaped the relationship between variant frequency and effect size. We leveraged the structure of the crosses to resolve hundreds of QTLs to single genes. These results refine our understanding of trait variation at the population level and suggest that studies of rare variants are a fertile ground for discovery of genetic effects
Recommended from our members
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes.
We aggregated coding variant data for 81,412 type 2 diabetes cases and 370,832 controls of diverse ancestry, identifying 40 coding variant association signals (P < 2.2 × 10-7); of these, 16 map outside known risk-associated loci. We make two important observations. First, only five of these signals are driven by low-frequency variants: even for these, effect sizes are modest (odds ratio ≤1.29). Second, when we used large-scale genome-wide association data to fine-map the associated variants in their regional context, accounting for the global enrichment of complex trait associations in coding sequence, compelling evidence for coding variant causality was obtained for only 16 signals. At 13 others, the associated coding variants clearly represent 'false leads' with potential to generate erroneous mechanistic inference. Coding variant associations offer a direct route to biological insight for complex diseases and identification of validated therapeutic targets; however, appropriate mechanistic inference requires careful specification of their causal contribution to disease predisposition
Landscape of stimulation-responsive chromatin across diverse human immune cells.
A hallmark of the immune system is the interplay among specialized cell types transitioning between resting and stimulated states. The gene regulatory landscape of this dynamic system has not been fully characterized in human cells. Here we collected assay for transposase-accessible chromatin using sequencing (ATAC-seq) and RNA sequencing data under resting and stimulated conditions for up to 32 immune cell populations. Stimulation caused widespread chromatin remodeling, including response elements shared between stimulated B and T cells. Furthermore, several autoimmune traits showed significant heritability in stimulation-responsive elements from distinct cell types, highlighting the importance of these cell states in autoimmunity. Allele-specific read mapping identified variants that alter chromatin accessibility in particular conditions, allowing us to observe evidence of function for a candidate causal variant that is undetected by existing large-scale studies in resting cells. Our results provide a resource of chromatin dynamics and highlight the need to characterize the effects of genetic variation in stimulated cells
A Bayesian Method for Detecting and Characterizing Allelic Heterogeneity and Boosting Signals in Genome-Wide Association Studies
The standard paradigm for the analysis of genome-wide association studies
involves carrying out association tests at both typed and imputed SNPs. These
methods will not be optimal for detecting the signal of association at SNPs
that are not currently known or in regions where allelic heterogeneity occurs.
We propose a novel association test, complementary to the SNP-based approaches,
that attempts to extract further signals of association by explicitly modeling
and estimating both unknown SNPs and allelic heterogeneity at a locus. At each
site we estimate the genealogy of the case-control sample by taking advantage
of the HapMap haplotypes across the genome. Allelic heterogeneity is modeled by
allowing more than one mutation on the branches of the genealogy. Our use of
Bayesian methods allows us to assess directly the evidence for a causative SNP
not well correlated with known SNPs and for allelic heterogeneity at each
locus. Using simulated data and real data from the WTCCC project, we show that
our method (i) produces a significant boost in signal and accurately identifies
the form of the allelic heterogeneity in regions where it is known to exist,
(ii) can suggest new signals that are not found by testing typed or imputed
SNPs and (iii) can provide more accurate estimates of effect sizes in regions
of association.Comment: Published in at http://dx.doi.org/10.1214/09-STS311 the Statistical
Science (http://www.imstat.org/sts/) by the Institute of Mathematical
Statistics (http://www.imstat.org
- …